Key Financial Data Of Group

Perseus Proteomics Inc. - Filing #7246059

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
120,375,000 JPY
100,402,000 JPY
94,201,000 JPY
71,932,000 JPY
67,947,000 JPY
Ordinary profit (loss)
-829,829,000 JPY
-879,380,000 JPY
-689,604,000 JPY
-481,681,000 JPY
-410,107,000 JPY
Net assets
1,432,406,000 JPY
1,398,344,000 JPY
2,396,545,000 JPY
3,152,154,000 JPY
1,083,713,000 JPY
Total assets
1,818,837,000 JPY
1,693,810,000 JPY
2,566,650,000 JPY
3,300,530,000 JPY
1,118,626,000 JPY
Net assets per share
91.74
110.94
201.13
268.05
128.86
Basic earnings (loss) per share
-63.41
-93.69
-66.93
-54.47
-59.03
Diluted earnings per share
Equity-to-asset ratio
0.7440 xbrli:pure
0.7818 xbrli:pure
0.9215 xbrli:pure
0.9550 xbrli:pure
0.9661 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-719,485,000 JPY
-833,898,000 JPY
-564,274,000 JPY
-476,842,000 JPY
-422,836,000 JPY
Net cash provided by (used in) investing activities
-75,157,000 JPY
-150,343,000 JPY
-212,989,000 JPY
-33,868,000 JPY
-2,824,000 JPY
Net cash provided by (used in) financing activities
923,381,000 JPY
63,943,000 JPY
-20,000 JPY
2,647,548,000 JPY
1,011,040,000 JPY
Cash and cash equivalents
1,667,921,000 JPY
1,541,419,000 JPY
2,444,934,000 JPY
3,214,852,000 JPY
1,069,300,000 JPY
Number of employees
32 xbrli:pure
25 xbrli:pure
24 xbrli:pure
21 xbrli:pure
19 xbrli:pure
Average number of temporary employees
2 xbrli:pure
3 xbrli:pure
1 xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.